The pre-seed round was led by Episode 1 with angel backing from executives at Wise, Revolut, Deliveroo, and Alphabet.
"When I found an error in my own tax return while testing the platform, I was shocked – I’d paid for professional help, I work in finance, and I was still left wondering whether everything had actually been done correctly. That simply shouldn’t still be the case in 2026,"
Thrive Capital is set to lead the financing round, which would value the artificial intelligence drug discovery startup at more than triple its previous raise.
The financing round was led by Thrive Capital with backing from GV and Alphabet.
"We’re excited to bring together a top-tier investor group with deep AI and life sciences expertise as we aim to transform this industry through an interdisciplinary approach."